Tag Archives: attendee

Look Who’s Coming to RESI NYC

19 Oct

By Lucy Parkinson, Director of Research, LSN

The first RESI NYC event has attracted a great diversity of constituents – from local startups to global investors, from New York-based foundations to major pharma and medtech firms from the Asia region. RESI always aims to draw investors beyond the well-trodden traditional funding tracks of venture capital funds, local angels and pharma; LSN is delighted to have those groups on board too, but at RESI you can also meet family offices, private equity and hedge funds, and the varied investment and strategic groups that participate in our Asia – North America track. Who would you like to meet at RESI NYC? Take a look below at some of the possibilities.

Confirmed Investors and Strategic Partners

As of October 19th, 2017

RESI Testimonials – Hear from the Folks Who Attended

29 Jun

By Michael Quigley, VP of Market Research, LSN

mike-2RESI San Diego was another successful event for fundraising life science companies, investors and strategic partners. With a great deal of praise coming from those on both sides of the investment table, you can read the testimonials below to see for yourself what industry executives are saying about RESI.

 

Brian Frenzel, MBA: Membership Committee, Band of Angels; President, CEO and Director Tosk, Inc.

Congratulations on a great RESI meeting in San Diego last week. I have been attending biomedical conferences for longer than I’d like to admit – ABC, ACA, ACOG, ASA, ASCO, BIO, DMD, H&Q, JPM, MnM, PhRMA, and many others, some whose acronyms are slowly being lost to history.

The RESI meeting in San Diego was one of the best organized and most productive that I have ever attended. The event’s sole focus on early stage investments and fundraising along with the partnering system made it very easy to identify companies of interest and schedule meetings. RESI staff were always available to help. The energy level was very high, and I was delighted to see so many new companies, new technologies, and new investors in attendance. Not only did I fill every meeting slot, but extended it into lunch, the reception, the following day, and the following week. I am confident that several companies I met at RESI will yield new business relationships.

My hat’s off to you and the RESI staff that made it possible!

Gregory Stein MD, MBA: President and CEO Curtana Pharmaceuticals

Congratulations on running yet another successful RESI conference! I have attended several over the past 3 years and they just keep getting better. The partnering system makes it easy to identify leads and I always have a packed meeting schedule with potential investors and partners that I could not have otherwise found through the usual channels. While I did not see immediate success, you and I both know this is, in part, a numbers game and persistence pays. It has taken a lot of work, but this past March I closed with one investor group and in July I will close with another group that has committed to invest. From the recent San Diego conference, I have several new high-quality investor leads and partnering opportunities to follow-up on in the coming weeks. Given the enthusiastic response I received to Curtana’s story, I anticipate that we will continue to benefit from the relationships we have made at the RESI conferences.

Yao Ho MBA: Business Development Director LYFE Capital

Attending numerous RESI from a few years back, I can say that the events are getting increasingly better and a must go to event to meet quality companies. Attendees from the investor side has also been increasing in quantity and quality, almost feeling like a 1:1 attendee ratio. The partnering system is intuitive to use and makes identifying promising companies to meet quite easy. From the event I have met many new business relationships that I expect will flourish in not only in the business setting but also as friends. Most importantly the follow-up rate from meetings held at RESI is also quite high, proving to me that the quality and dedication of these companies are certainly a par above. The RESI team has always been helpful in addressing any concerns and helping build new leads. I am certain that we will be attending future RESI events and look forward to seeing RESI flourish. Congrats to the RESI team on making another great event!

Look Who’s Coming To RESI on MaRS

5 May

By Lucy Parkinson, Director of Research, LSN

With RESI heading to Toronto for the first time, LSN has been delighted to find that many investors are interested in coming to MaRS to get involved in Toronto’s healthcare innovation hub. Ranging from local Ontario funds to firms from the far side of the world, these investors will gather on June 23rd to meet with startup companies from Canada and beyond. If you’d like to join us at RESI on MaRS to book meetings with these investors and more, register here.

RESI on MaRS Confirmed Investors 05-03-16

Who Will You Meet at RESI San Francisco?

7 Jan

By Cole Bunn, Research Analyst, LSN

cole-wp

Life Science Nation’s mission of connecting scientist entrepreneurs with capital gave rise to the Redefining Early Stage Investments (RESI) conference nearly 3 years ago. As we approach our seventh RESI conference, during the highly anticipated JP Morgan week in San Francisco, we’re expecting a record of well over 300 investors representing over 200 different firms in attendance. Figure 1 shows a breakdown of investors by type who will be at RESI San Francisco on January 12, 2016. You can also view the firms represented here.

Venture capital is the most represented investor type, and this includes a growing number of non-traditional venture firms in today’s investment landscape. For instance, the relatively new emergence of the “micro VC” has more capital flowing into seed and series A stage companies. As shown here, several other investor classes looking for early-stage life science technologies that don’t fall under the venture capital umbrella also have a large presence at the RESI conference. This diversity of investors means that RESI Partnering can provide RESI’s great variety of attendees with the opportunity to make a connection with a financing partner that’s the right fit for their round.

Life Science Nation’s network of varied investor types will be showcased on an assortment of panels throughout the day. The 16 panels scheduled to take place at RESI San Francisco will cover the full range of companies in the life science space (biotech, medtech, diagnostic and health IT) and the different investor class’ tactical guidance for navigating the investment process of their respective niches and outlook on the future of each sector. The LSN research team’s unique perspective on the investment landscape has spurred a new panel that will be held for the first time at RESI San Francisco, Consumer Health “Investing in Innovative Products for Healthy Living,” and the return of two panels from former RESI events, Asia-Pacific Investors, “Forging Cross-Border Collaborations in Healthcare,” and Orphan & Rare Disease Investors, “Seeking Returns On Investing In Small Patient Populations”.

The fundraising process is typically a lengthy one, therefore multiple interactions with prospective investors and strategic partners are essential to a successful campaign. The RESI conference is an ongoing series that provides just that, allowing entrepreneurs to interface with a diverse field of investors, foster existing relationships and make new connections throughout the year, at multiple events. RESI San Francisco is just the first stop for 2016, with additional RESI conferences being held in Houston, Toronto and Boston, later in the year.

This ongoing chain of conferences coupled with the forward-looking investor mandate information used in our partnering platform really makes RESI stand out in terms of the ability to make meaningful connections. To see a demonstration of just how effective the partnering system can be at finding a match, please watch this video.

https://www.youtube.com/watch?v=z9xpbQk7ja4